1Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin North Am, 1996,6: 379-407.
2Chen YK, Foliente RL, Santoro MJ, et al. Endoscopic sphincterotomy-induced pancreatitis: Increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol ,1994,89: 327-333.
3Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med, 1996, 335:919-923.
4Matsumura T, Yada S, Miyoshi Y, et al. Effect of synthetic protease inhibitor on the sphincter of Oddi function in dogs. Nippon Shokakibyo Gakkai Zasshi, 1991, 88:2663-2670.
5Di Francesco V, Marriani A, Angelini G , et al. Effects of gabexate mesilate,a protease inhibitor, on human sphincter of Oddi motility.Dig Dis Sci, 2002, 47:741-745.